Oxitec

About:

Oxitec develops an environment-friendly technology for the control of significant insect pests to prevent diseases and agricultural damage.

Website: http://www.oxitec.com

Twitter/X: oxitec

Top Investors: Wellcome Trust, Bill & Melinda Gates Foundation, Oxford Capital, East Hill Management, East Hill Advisors

Description:

Oxitec is developing and commercialising an effective and environment-friendly proprietary technology for the control of significant insect pests. Oxitec’s technology has the potential to make a major contribution for both global health and agriculture by combating insects responsible for serious diseases such as dengue fever as well as agricultural damage. The proprietary technology builds on inventions from the University of Oxford and employs genetics and molecular biology to enhance the cost-effectiveness and safety of the existing Sterile Insect Technique (SIT), and to extend SIT to a broader range of insect pests.

Total Funding Amount:

$65.4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Abingdon, Oxfordshire, United Kingdom

Founded Date:

2002-01-01

Contact Email:

info(AT)oxitec.com

Founders:

Luke Alphey

Number of Employees:

51-100

Last Funding Date:

2022-04-13

IPO Status:

Private

Industries:

© 2025 bioDAO.ai